查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
抗菌素耐藥性診斷市場規模、份額和趨勢分析報告：按技術（微生物培養、免疫測定、PCR、NGS）、病原體、最終用戶、地區、細分市場預測 2022-2030 年
市場調查報告書
商品編碼
1170858

抗菌素耐藥性診斷市場規模、份額和趨勢分析報告：按技術（微生物培養、免疫測定、PCR、NGS）、病原體、最終用戶、地區、細分市場預測 2022-2030 年

Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report By Technology (Microbiology Culture, Immunoassay, PCR, NGS), By Pathogen, By End User, By Region, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

抗菌素耐藥性診斷市場的增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球抗菌素耐藥性診斷市場預計將達到 67 億美元。 從 2022 年到 2030 年，該市場預計將以 6.2% 的複合年增長率增長。 發生耐藥性感染的風險不斷增加，尤其是在醫療機構中，以及政府和非政府組織為應對 AMR 威脅所做的越來越多的努力是市場增長的主要驅動力。 市場參與者為管理抗菌素耐藥性而採取的各種戰略舉措也有助於市場擴張。 例如，2021 年 3 月，bioMerieux 和 GIZ 聯手幫助尼日利亞疾病控制中心加強對抗 AMR 的鬥爭。

由於對耐藥感染的快速檢測和 PoC 檢測越來越多地被採用，預計該市場在預測期內將會擴大。 此外，丹納赫和雅培等主要市場參與者擁有強大的抗菌素耐藥性感染快速診斷檢測產品組合。 此外，AMR 行業聯盟等非政府組織越來越多地參與協助監管機構制定戰略，以支持開發管理抗菌素耐藥性的診斷解決方案。

用於開髮用於診斷抗菌素耐藥性感染的新型自動化檢測解決方案的資金不斷增加，預計將在預測期內推動市場增長。 例如，2022 年 5 月，歐洲投資銀行授予 POCARED Diagnostics 超過 2400 萬美元，用於研究和開發針對微生物疾病的全自動測試。 POCARED Diagnostics 參與開發可在數小時內提供結果的新型微生物測試。

預計未來幾年抗菌素耐藥性會增加。 因此，為了有效管理和監測抗菌素耐藥性的進展，對準確和快速檢測選項的需求預計會增加。 根據疾病預防控制中心的數據，在美國，由於抗菌素耐藥性導致的年度直接醫療費用約為 200 億美元。

主要市場參與者不斷致力於開發新的測試以鞏固其市場地位。 此外，主要參與者還採用其他戰略，如收購、合作夥伴關係和合作，以擴大其在世界不同地區的產品組合。 例如，2022 年 8 月，Accelerate Diagnostics 和 BD 宣布合作應對抗菌素耐藥性的威脅。 通過該協議，BD 將向其龐大的客戶群提供 Accelerate Diagnostics 針對抗生素相關耐藥性的快速診斷解決方案。

抗微生物藥物耐藥性診斷市場報告要點

2021年技術領域，PCR憑藉其高滲透率和技術進步佔據最大份額

按病原體劃分，2021年MRSA感染高發、產品上市激增，耐甲氧西林金黃色葡萄球菌佔比最大

在最終用戶中，由於患者住院率高和細菌感染率高，2021 年醫院板塊的銷售額貢獻最大

由於市場參與者增加投資和增加研究活動，預計亞太地區在預測期內將呈現最快的增長

內容

第1章調查方法及範圍

  • 市場細分和範圍
    • 細分範圍
    • 區域範圍
  • 調查方法
  • 信息採購
    • 購買的數據庫：
    • GVR 內部數據庫
    • 次要信息
    • 初步調查
    • 初步調查的內容
  • 信息或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細信息
    • 商品流分析
      • 方法：產品流方法
  • 調查假設
  • 二級信息列表
  • 縮寫列表
  • 目的

第 2 章執行摘要

  • 市場展望
  • 競爭考慮

第 3 章抗菌素耐藥性診斷市場：變量、趨勢和範圍

  • 市場系列展望
    • 母公司市場
  • 市場動態
    • 市場驅動因素分析
      • 發生耐藥性感染的風險增加
      • 介紹用於診斷 AMR 感染的新技術
      • 有利的政府舉措
    • 市場製約因素分析
      • 存在關於診斷的嚴格規則和規定
  • 描繪滲透率和增長前景
  • 抗菌素耐藥性診斷：市場分析工具
    • 行業分析 - 搬運工
    • PESTLE 分析
  • 監管框架
  • 價格分析

第 4 章抗菌素耐藥性診斷市場：按技術細分分析，2018-2030

  • 定義和範圍
  • 2021 年和 2030 年技術市場份額分析
  • 部門儀表板
  • 全球抗菌素耐藥性診斷市場，按技術劃分，2018-2030 年
  • 2018-2030 年市場規模和預測、趨勢分析
    • 微生物培養
    • 免疫測定
    • 聚合□鏈反應
    • 下一代測序
    • 質譜
    • 快速和護理點
    • 其他

第 5 章抗菌素耐藥性診斷市場：細分分析，按病原體，2018-2030

  • 定義和範圍
  • 2021 年和 2030 年病原體市場份額分析
  • 部門儀表板
  • 全球抗菌素耐藥性診斷市場，按病原體，2018-2030 年
  • 2018-2030 年市場規模和預測、趨勢分析
    • 耐藥性肺炎鏈球菌 (DRSP)
    • 耐藥彎曲桿菌 (DRC)
    • 艱難梭菌 (CD)
    • 耐甲氧西林金黃色葡萄球菌 (MRSA)
    • 抗藥性淋病奈瑟菌 (DRNG)
    • 耐藥沙門氏菌 (DRNTS)
    • 其他

第 6 章抗菌素耐藥性診斷市場：細分分析，按最終用戶分類，2018-2030

  • 定義和範圍
  • 2021 年和 2030 年最終用戶市場份額分析
  • 部門儀表板
  • 全球抗菌素耐藥性診斷市場，按最終用戶劃分，2018-2030 年
  • 2018-2030 年市場規模和預測、趨勢分析
    • 醫院
    • 診斷實驗室
    • 製藥和生物技術公司
    • 其他

第 7 章抗菌素耐藥性診斷市場：按地區劃分的細分分析，2018-2030

  • 定義和範圍
  • 2021 年和 2030 年區域市場份額分析
  • 區域市場儀表板
  • 區域市場概況
  • SWOT 分析
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 2018-2030 年市場規模、預測、收入和趨勢分析
    • 北美
      • 美國
      • 加拿大
    • 歐洲
      • 英國
      • 德國
      • 西班牙
      • 法國
      • 意大利
    • 亞太地區
      • 日本
      • 中國
      • 印度
      • 韓國
      • 澳大利亞
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 多邊環境協定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯聯合酋長國

第 8 章抗菌素耐藥性診斷市場：競爭分析

  • 主要市場進入者的近期趨勢和影響分析
    • 安索夫矩陣
    • 熱圖分析
    • 主要交易和戰略聯盟分析
      • 合資企業
      • 許可協議
      • 產品發布
      • 會議和活動
  • 公司分類
    • 創新者
    • 市場領導者
  • 供應商情況
    • 主要分銷商和渠道合作夥伴列表
    • 主要客戶
  • 上市公司
    • 競爭儀表板分析
      • 市場差異化因素
  • 私人公司
    • 主要初創公司名單
  • 公司簡介
    • 生物梅裡埃
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • F. Hoffmann-La Roche Ltd.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 雅培
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 商務部
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 丹納赫
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Accelerate Diagnostics, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 摩爾斯德
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 維拉診斷
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • 維斯比醫療公司
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • Hologic, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-990-4

Antimicrobial Resistance Diagnostics Market Growth & Trends:

The global antimicrobial resistance diagnostics market size is expected to reach USD 6.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2022 to 2030. The increased risk of developing drug-resistant bacterial infections, especially in healthcare facilities, and increasing government & non-government bodies' efforts to combat the threat of AMR are the major factor contributing to market growth. In addition, various strategic initiatives undertaken by leading market players to manage antimicrobial resistance are also contributing to market expansion. For instance, in March 2021, bioMerieux and GIZ collaborated to support the Nigerian center for disease control to strengthen the fight against AMR.

The rising adoption of rapid testing and PoC tests for drug-resistant bacterial infections is anticipated to augment the market over the projected period. Moreover, leading market players such as Danaher, Abbott, and others have a robust product portfolio of rapid diagnostic tests for antimicrobial-resistant infections. Furthermore, the increasing involvement of non-government bodies such as AMR Industry Alliance is assisting regulatory bodies to make strategies to boost the development of diagnostic solutions to manage antimicrobial resistance.

Increasing funding for the development of novel and automated test solutions for the diagnosis of antimicrobial-resistant infections is anticipated to boost market growth over the forecast period. For instance, in May 2022, the European Investment Bank funded more than USD 24 million to POCARED Diagnostics for the R&D of fully automated testing of microbial diseases. POCARED Diagnostics is involved in the development of novel microbiology tests that can provide results within hours.

Antimicrobial resistance is expected to rise in the coming years. Hence, demand for accurate & fast testing options is expected to increase for the effective management and progression monitoring of antimicrobial resistance. According to the CDC, the annual direct healthcare expenditure of antimicrobial resistance is around USD 20 billion in the U.S. High cost of disease management is driving the demand for rapid tests for the diagnosis of infections at an early stage.

Key market players are continuously involved in the development of novel tests to strengthen their market position. Moreover, other strategies such as acquisitions, partnerships, and collaborations are also adopted by leading players to expand their product portfolio in different parts of the globe. For instance, in August 2022, Accelerate Diagnostics and BD announced a collaboration to combat the threat of antimicrobial resistance. As per the deal, BD will provide Accelerate Diagnostics rapid diagnostic solutions for antibiotics-associated resistance to its vast customers.

Antimicrobial Resistance Diagnostics Market Report Highlights:

  • PCR held the largest share of the technology segment in 2021 owing to the high penetration and technological advancements
  • Based on pathogen segment, the Methicillin resistant staphylococcus aureus accounted for the largest share in 2021 due to the high incidence rate of MRSA infections and the surge in product launches
  • In end-user, the hospital segment was the highest revenue contributor in 2021 because of higher patient admissions and high incidence of bacterial infections
  • In Asia Pacific, the market is expected to exhibit the fastest growth over the forecast period due to the rising investments by market players and increasing research activities in the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Competitive Insights

Chapter 3 Antimicrobial Resistance Diagnostics Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market
  • 3.2 Market Dynamics
    • 3.2.1 Market drivers analysis
      • 3.2.1.1 Increase in risk of developing drug - resistant bacterial infections
      • 3.2.1.2 Introduction of novel technologies to diagnose AMR infections
      • 3.2.1.3 Favorable government initiatives
    • 3.2.2 Market restraint analysis
      • 3.2.2.1 Presence of stringent rules and regulations pertaining to diagnostics
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Antimicrobial Resistance Diagnostics: Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
    • 3.4.2 PESTLE analysis
  • 3.5 Regulatory Framework
  • 3.6 Pricing Analysis

Chapter 4 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Technology Market Share Analysis, 2021 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Antimicrobial Resistance Diagnostics Market, by Technology, 2018 to 2030
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.5.1 Microbiology Culture
      • 4.5.1.1 Microbiology culture market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2 Immunoassay
      • 4.5.2.1 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3 PCR
      • 4.5.3.1 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.4 NGS
      • 4.5.4.1 NGS market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.5 Mass Spectrometry
      • 4.5.5.1 Mass Spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.6 Rapid & Point of Care
      • 4.5.6.1 Rapid & Point of Care market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.7 Others
      • 4.5.7.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Pathogen 2018 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 Pathogen Market Share Analysis, 2021 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Antimicrobial Resistance Diagnostics Market, by Pathogen, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Drug Resistant Streptococcus Pneumoniae (DRSP)
      • 5.5.1.1 Drug resistant streptococcus pneumoniae (DRSP) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.2 Drug Resistant Campylobacter (DRC)
      • 5.5.2.1 Drug resistant campylobacter (DRC) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.3 Clostridium Difficile (CD)
      • 5.5.3.1 Clostridium difficile (CD) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.4 Methicillin Resistant Staphylococcus Aureus (MRSA)
      • 5.5.4.1 Methicillin resistant staphylococcus aureus (MRSA) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.5 Drug Resistant Neisseria Gonorrhoeae (DRNG)
      • 5.5.5.1 Drug resistant neisseria gonorrhoeae (DRNG) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.6 Drug Resistant Salmonella (DRNTS)
      • 5.5.6.1 Drug resistant salmonella (DRNTS) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 5.5.7 Others
      • 5.5.7.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6 Antimicrobial Resistance Diagnostics Market Segment Analysis, By End User, 2018 - 2030 (USD Million)

  • 6.1 Definition and Scope
  • 6.2 End User Market Share Analysis, 2021 & 2030
  • 6.3 Segment Dashboard
  • 6.4 Global Antimicrobial Resistance Diagnostics Market, by End User, 2018 to 2030
  • 6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 6.5.1 Hospitals
      • 6.5.1.1 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.2 Diagnostic Laboratories
      • 6.5.2.1 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3 Pharmaceutical & Biotechnology Companies
      • 6.5.3.1 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4 Others
      • 6.5.4.1 Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Antimicrobial Resistance Diagnostics Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 7.1 Definition & Scope
  • 7.2 Regional Market Share Analysis, 2021 & 2030
  • 7.3 Regional Market Dashboard
  • 7.4 Regional Market Snapshot
  • 7.5 SWOT Analysis
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia Pacific
    • 7.5.4 Latin America
    • 7.5.5 Middle East and Africa
  • 7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
    • 7.6.1 North America
      • 7.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
      • 7.6.1.2 U.S.
      • 7.6.1.2.1 U.S. antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.1.3 Canada
      • 7.6.1.3.1 Canada antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.2 Europe
      • 7.6.2.1 Europe antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.2.2 U.K.
      • 7.6.2.2.1 U.K. antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.2.3 Germany
      • 7.6.2.3.1 Germany antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.2.4 Spain
      • 7.6.2.4.1 Spain antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.2.5 France
      • 7.6.2.5.1 France antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.2.6 Italy
      • 7.6.2.6.1 Italy antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.3 Asia Pacific
      • 7.6.3.1 Asia Pacific antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.3.2 Japan
      • 7.6.3.2.1 Japan antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.3.3 China
      • 7.6.3.3.1 China antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.3.4 India
      • 7.6.3.4.1 India antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.3.5 South Korea
      • 7.6.3.5.1 South Korea antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.3.6 Australia
      • 7.6.3.6.1 Australia antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.4 Latin America
      • 7.6.4.1 Latin America antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.4.2 Brazil
      • 7.6.4.2.1 Brazil antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.4.3 Mexico
      • 7.6.4.3.1 Mexico antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.4.4 Argentina
      • 7.6.4.4.1 Argentina antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 7.6.5 MEA
      • 7.6.5.1 MEA antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.5.2 South Africa
      • 7.6.5.2.1 South Africa antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.5.3 Saudi Arabia
      • 7.6.5.3.1 Saudi Arabia antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
      • 7.6.5.4 UAE
      • 7.6.5.4.1 UAE antimicrobial resistance diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 8 Antimicrobial Resistance Diagnostics Market - Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 8.1.1 Ansoff matrix
    • 8.1.2 Heat map analysis
    • 8.1.3 Major Deals and Strategic Alliances Analysis
      • 8.1.3.1 Joint Ventures
      • 8.1.3.2 Licensing Agreements
      • 8.1.3.3 Product Launches
      • 8.1.3.4 Conferences and Campaigns
  • 8.2 Company Categorization
    • 8.2.1 Innovators
    • 8.2.2 Market Leaders
  • 8.3 Vendor Landscape
    • 8.3.1 List of key distributors and channel partners
    • 8.3.2 Key customers
  • 8.4 Public Companies
    • 8.4.1 Competitive Dashboard Analysis
      • 8.4.1.1 Market Differentiators
  • 8.5 Private Companies
    • 8.5.1 List of key emerging companies
  • 8.6 Company Profiles
    • 8.6.1 bioMerieux
      • 8.6.1.1 Company overview
      • 8.6.1.2 Financial performance
      • 8.6.1.3 Product benchmarking
      • 8.6.1.4 Strategic initiatives
    • 8.6.2 F. Hoffmann - La Roche Ltd
      • 8.6.2.1 Company overview
      • 8.6.2.2 Financial performance
      • 8.6.2.3 Product benchmarking
      • 8.6.2.4 Strategic initiatives
    • 8.6.3 Abbott
      • 8.6.3.1 Company overview
      • 8.6.3.2 Financial performance
      • 8.6.3.3 Product benchmarking
      • 8.6.3.4 Strategic initiatives
    • 8.6.4 BD
      • 8.6.4.1 Company overview
      • 8.6.4.2 Financial performance
      • 8.6.4.3 Product benchmarking
      • 8.6.4.4 Strategic initiatives
    • 8.6.5 Danaher
      • 8.6.5.1 Company overview
      • 8.6.5.2 Financial performance
      • 8.6.5.3 Product benchmarking
      • 8.6.5.4 Strategic initiatives
    • 8.6.6 Accelerate Diagnostics, Inc.
      • 8.6.6.1 Company overview
      • 8.6.6.2 Financial performance
      • 8.6.6.3 Product benchmarking
      • 8.6.6.4 Strategic initiatives
    • 8.6.7 Molsid
      • 8.6.7.1 Company overview
      • 8.6.7.2 Financial performance
      • 8.6.7.3 Product benchmarking
      • 8.6.7.4 Strategic initiatives
    • 8.6.8 Vela Diagnostics
      • 8.6.8.1 Company overview
      • 8.6.8.2 Financial performance
      • 8.6.8.3 Product benchmarking
      • 8.6.8.4 Strategic initiatives
    • 8.6.9 Visby Medical, Inc.
      • 8.6.9.1 Company overview
      • 8.6.9.2 Financial performance
      • 8.6.9.3 Product benchmarking
      • 8.6.9.4 Strategic initiatives
    • 8.6.10 Hologic, Inc.
      • 8.6.10.1 Company overview
      • 8.6.10.2 Financial performance
      • 8.6.10.3 Product benchmarking
      • 8.6.10.4 Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Leading market players anticipated to witness highest growth
  • Table 4 Global Antimicrobial Resistance Diagnostics Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 6 Global Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
  • Table 7 Global Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 8 North America Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 9 North America Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 10 North America Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 11 North America Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 12 U.S. Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 13 U.S. Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
  • Table 14 U.S. Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 15 Canada Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 16 Canada Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
  • Table 17 Canada Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 18 Europe Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 19 Europe Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 20 Europe Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 21 Europe Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 22 Germany Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 23 Germany Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
  • Table 24 Germany Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 25 France Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 26 France Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 27 France Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 28 U.K. Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 29 U.K. Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 30 U.K. Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 31 Spain Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 32 Spain Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
  • Table 33 Spain Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 34 Spain Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 35 Italy Antimicrobial Resistance Diagnostics Market, By Pathology, 2018 - 2030 (USD Million)
  • Table 36 Italy Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 37 Italy Antimicrobial Resistance Diagnostics Market, By Application, 2018 - 2030 (USD Million)
  • Table 38 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 39 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 42 Japan Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 43 Japan Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 44 Japan Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 45 China Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 46 China Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 47 China Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 48 India Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 49 India Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 50 India Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 51 Australia Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 52 Australia Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 53 Australia Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 54 South Korea Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 55 South Korea Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 56 South Korea Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 57 Latin America Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 58 Latin America Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 59 Latin America Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 60 Latin America Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 61 Brazil Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 62 Brazil Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 63 Brazil Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 64 Mexico Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 65 Mexico Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 66 Mexico Antimicrobial Resistance Diagnostics Market, By End Use, 2018 - 2030 (USD Million)
  • Table 67 Argentina Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 68 Argentina Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 69 Argentina Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 70 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Country, 2018 - 2030 (USD Million)
  • Table 71 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 72 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa Antimicrobial Resistance Diagnostics Market, By End-user, 2018 - 2030 (USD Million)
  • Table 74 South Africa Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 75 South Africa Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 76 South Africa Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 77 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 78 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia Antimicrobial Resistance Diagnostics Market, By End User, 2018 - 2030 (USD Million)
  • Table 80 UAE Antimicrobial Resistance Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
  • Table 81 UAE Antimicrobial Resistance Diagnostics Market, By Pathogen, 2018 - 2030 (USD Million)
  • Table 82 UAE Antimicrobial Resistance Diagnostics Market, By End-user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Antimicrobial resistance diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2020)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Antimicrobial resistance diagnostics market: technology movement analysis
  • Fig. 17 Antimicrobial resistance diagnostics market: technology segment dashboard
  • Fig. 18 Antimicrobial resistance diagnostics market technology outlook: Key takeaways
  • Fig. 19 Microbiology culture market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 PCR market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 NGS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Rapid & point of care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Antimicrobial resistance diagnostics market: pathogen analysis
  • Fig. 27 Antimicrobial resistance diagnostics market: pathogen segment dashboard
  • Fig. 28 Antimicrobial resistance diagnostics market pathogen outlook: Key takeaways
  • Fig. 29 Drug Resistant Streptococcus Pneumoniae (DRSP) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug Resistant Campylobacter (DRC)market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Clostridium Difficile (CD) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Methicillin Resistant Staphylococcus Aureus (MRSA)market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Drug Resistant Neisseria Gonorrhoeae (DRNG) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Drug Resistant Salmonella (DRNTS) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Antimicrobial resistance diagnostics market: end user movement analysis
  • Fig. 37 Antimicrobial resistance diagnostics market: end user segment dashboard
  • Fig. 38 Antimicrobial resistance diagnostics market, end user outlook: Key takeaways
  • Fig. 39 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Diagnostic laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Regional outlook estimates and forecasts, 2021 & 2030
  • Fig. 44 Regional market dashboard
  • Fig. 45 Regional market place: Key takeaways
  • Fig. 46 North America, SWOT
  • Fig. 47 Europe, SWOT
  • Fig. 48 Asia Pacific, SWOT
  • Fig. 49 Latin America, SWOT
  • Fig. 50 Middle East and Africa, SWOT
  • Fig. 51 North America
  • Fig. 52 North America antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 53 U.S.
  • Fig. 54 U.S. antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 55 Canada
  • Fig. 56 Canada antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 57 Europe
  • Fig. 58 Europe antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 59 U.K.
  • Fig. 60 U.K. antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 61 Germany
  • Fig. 62 Germany antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 63 Spain
  • Fig. 64 Spain antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 65 France
  • Fig. 66 France antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 67 Italy
  • Fig. 68 Italy antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 69 Asia Pacific
  • Fig. 70 Asia Pacific antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 71 Japan
  • Fig. 72 Japan antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 73 China
  • Fig. 74 China antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 75 India
  • Fig. 76 India antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 77 South Korea
  • Fig. 78 South Korea antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 79 Australia
  • Fig. 80 Australia antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 81 Latin America
  • Fig. 82 Latin America antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 83 Brazil
  • Fig. 84 Brazil antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 85 Mexico
  • Fig. 86 Mexico antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 87 Argentina
  • Fig. 88 Argentina antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 89 Middle East and Africa
  • Fig. 90 MEA antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 91 South Africa
  • Fig. 92 South Africa antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 93 Saudi Arabia
  • Fig. 94 Saudi Arabia antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 95 UAE
  • Fig. 96 UAE antimicrobial resistance diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 97 Ansoff Matrix
  • Fig. 98 Heat map analysis
  • Fig. 99 Market differentiators